0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Erectile Dysfunction Drugs Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028
Published Date: September 2022
|
Report Code: QYRE-Auto-7X5184
Home | Market Reports | Health| Reproductive Health
Global Erectile Dysfunction Drugs Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027
BUY CHAPTERS

Global Erectile Dysfunction Drugs Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Code: QYRE-Auto-7X5184
Report
September 2022
116 Pages
QYResearch
Region: Global
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
Erectile dysfunction (ED), also known as impotence, is a type of sexual dysfunction characterized by the inability to develop or maintain an erection of the penis during sexual activity. Erectile dysfunction can have psychological consequences as it can be tied to relationship difficulties and self-image.
Highlights

Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Erectile Dysfunction Drugs market is projected to reach US$ 7335.2 million by 2028 from an estimated US$ 5171.1 million in 2022, at a CAGR of 6.0% during 2023 and 2028.

North America is the largest Erectile Dysfunction Drugs market with about 39% market share. Europe is follower, accounting for about 30% market share.
The key players are Eli Lilly, Pfizer, Bayer, BaiYunShan General Factory, S.K. Chemicals, Teva Pharma, Dong-A ST, Metuchen Pharma, Seoul Pharma, CSBIO. etc. Top 3 companies occupied about 57% market share.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Erectile Dysfunction Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Erectile Dysfunction Drugs.
The Erectile Dysfunction Drugs market size, estimations, and forecasts are provided in terms of sales volume (M Pill) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Erectile Dysfunction Drugs market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Erectile Dysfunction Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Eli Lilly
Pfizer
Bayer
BaiYunShan General Factory
S.K. Chemicals
Teva Pharma
Dong-A ST
Metuchen Pharma
Seoul Pharma
CSBIO.
Product Type Insights
Global markets are presented by Erectile Dysfunction Drugs type, along with growth forecasts through 2028. Estimates on sales and revenue are based on the price in the supply chain at which the Erectile Dysfunction Drugs are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).

Erectile Dysfunction Drugs Segment by Type

Sildenafil
Tadalafil
Others
Application Insights
This report has provided the market size (sales and revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).
This report also outlines the market trends of each segment and consumer behaviors impacting the Erectile Dysfunction Drugs market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Erectile Dysfunction Drugs market.

Erectile Dysfunction Drugs Segment by Application

Hospital Pharmacies
Private Clinics
Retail Pharmacies
E-Commerce (B2B)
E-Commerce (B2C)
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Erectile Dysfunction Drugs market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Erectile Dysfunction Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Erectile Dysfunction Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Erectile Dysfunction Drugs industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Erectile Dysfunction Drugs

This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution

1 Study Coverage
1.1 Erectile Dysfunction Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Erectile Dysfunction Drugs Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Sildenafil
1.2.3 Tadalafil
1.2.4 Others
1.3 Market by Application
1.3.1 Global Erectile Dysfunction Drugs Market Size Growth Rate by Application (2017 VS 2021 VS 2028)
1.3.2 Hospital Pharmacies
1.3.3 Private Clinics
1.3.4 Retail Pharmacies
1.3.5 E-Commerce (B2B)
1.3.6 E-Commerce (B2C)
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Erectile Dysfunction Drugs Market Size Estimates and Forecasts
2.1.1 Global Erectile Dysfunction Drugs Revenue 2017-2028
2.1.2 Global Erectile Dysfunction Drugs Sales 2017-2028
2.2 Erectile Dysfunction Drugs Market Size by Region: 2022 Versus 2028
2.3 Erectile Dysfunction Drugs Sales by Region (2017-2028)
2.3.1 Global Erectile Dysfunction Drugs Sales by Region: 2017-2022
2.3.2 Global Erectile Dysfunction Drugs Sales Forecast by Region (2023-2028)
2.3.3 Global Erectile Dysfunction Drugs Sales Market Share by Region (2017-2028)
2.4 Erectile Dysfunction Drugs Market Estimates and Projections by Region (2023-2028)
2.4.1 Global Erectile Dysfunction Drugs Revenue by Region: 2017-2022
2.4.2 Global Erectile Dysfunction Drugs Revenue Forecast by Region (2023-2028)
2.4.3 Global Erectile Dysfunction Drugs Revenue Market Share by Region (2017-2028)
3 Global Erectile Dysfunction Drugs by Manufacturers
3.1 Global Top Erectile Dysfunction Drugs Manufacturers by Sales
3.1.1 Global Erectile Dysfunction Drugs Sales by Manufacturer (2017-2022)
3.1.2 Global Erectile Dysfunction Drugs Sales Market Share by Manufacturer (2017-2022)
3.2 Global Top Erectile Dysfunction Drugs Manufacturers by Revenue
3.2.1 Global Erectile Dysfunction Drugs Revenue by Manufacturer (2017-2022)
3.2.2 Global Erectile Dysfunction Drugs Revenue Share by Manufacturer (2017-2022)
3.3 Global Erectile Dysfunction Drugs Price by Manufacturer (2017-2022)
3.4 Competitive Landscape
3.4.1 Key Erectile Dysfunction Drugs Manufacturers Covered: Ranking by Revenue
3.4.2 Global Erectile Dysfunction Drugs Market Concentration Ratio (CR5 and HHI) & (2017-2022)
3.4.3 Global Erectile Dysfunction Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Erectile Dysfunction Drugs Manufacturing Base Distribution, Product Type
3.5.1 Erectile Dysfunction Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Erectile Dysfunction Drugs Product Type
3.5.3 Date of International Manufacturers Enter into Erectile Dysfunction Drugs Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Eli Lilly
4.1.1 Eli Lilly Corporation Information
4.1.2 Eli Lilly Description, Business Overview
4.1.3 Eli Lilly Erectile Dysfunction Drugs Products Offered
4.1.4 Eli Lilly Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2017-2022)
4.1.5 Eli Lilly Erectile Dysfunction Drugs Sales by Product in 2021
4.1.6 Eli Lilly Erectile Dysfunction Drugs Sales by Application in 2021
4.1.7 Eli Lilly Erectile Dysfunction Drugs Sales by Geographic Area in 2021
4.1.8 Eli Lilly Recent Developments
4.2 Pfizer
4.2.1 Pfizer Corporation Information
4.2.2 Pfizer Description, Business Overview
4.2.3 Pfizer Erectile Dysfunction Drugs Products Offered
4.2.4 Pfizer Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2017-2022)
4.2.5 Pfizer Erectile Dysfunction Drugs Sales by Product in 2021
4.2.6 Pfizer Erectile Dysfunction Drugs Sales by Application in 2021
4.2.7 Pfizer Erectile Dysfunction Drugs Sales by Geographic Area in 2021
4.2.8 Pfizer Recent Developments
4.3 Bayer
4.3.1 Bayer Corporation Information
4.3.2 Bayer Description, Business Overview
4.3.3 Bayer Erectile Dysfunction Drugs Products Offered
4.3.4 Bayer Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2017-2022)
4.3.5 Bayer Erectile Dysfunction Drugs Sales by Product in 2021
4.3.6 Bayer Erectile Dysfunction Drugs Sales by Application in 2021
4.3.7 Bayer Erectile Dysfunction Drugs Sales by Geographic Area in 2021
4.3.8 Bayer Recent Developments
4.4 BaiYunShan General Factory
4.4.1 BaiYunShan General Factory Corporation Information
4.4.2 BaiYunShan General Factory Description, Business Overview
4.4.3 BaiYunShan General Factory Erectile Dysfunction Drugs Products Offered
4.4.4 BaiYunShan General Factory Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2017-2022)
4.4.5 BaiYunShan General Factory Erectile Dysfunction Drugs Sales by Product in 2021
4.4.6 BaiYunShan General Factory Erectile Dysfunction Drugs Sales by Application in 2021
4.4.7 BaiYunShan General Factory Erectile Dysfunction Drugs Sales by Geographic Area in 2021
4.4.8 BaiYunShan General Factory Recent Developments
4.5 S.K. Chemicals
4.5.1 S.K. Chemicals Corporation Information
4.5.2 S.K. Chemicals Description, Business Overview
4.5.3 S.K. Chemicals Erectile Dysfunction Drugs Products Offered
4.5.4 S.K. Chemicals Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2017-2022)
4.5.5 S.K. Chemicals Erectile Dysfunction Drugs Sales by Product in 2021
4.5.6 S.K. Chemicals Erectile Dysfunction Drugs Sales by Application in 2021
4.5.7 S.K. Chemicals Erectile Dysfunction Drugs Sales by Geographic Area in 2021
4.5.8 S.K. Chemicals Recent Developments
4.6 Teva Pharma
4.6.1 Teva Pharma Corporation Information
4.6.2 Teva Pharma Description, Business Overview
4.6.3 Teva Pharma Erectile Dysfunction Drugs Products Offered
4.6.4 Teva Pharma Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2017-2022)
4.6.5 Teva Pharma Erectile Dysfunction Drugs Sales by Product in 2021
4.6.6 Teva Pharma Erectile Dysfunction Drugs Sales by Application in 2021
4.6.7 Teva Pharma Erectile Dysfunction Drugs Sales by Geographic Area in 2021
4.6.8 Teva Pharma Recent Development
4.7 Dong-A ST
4.7.1 Dong-A ST Corporation Information
4.7.2 Dong-A ST Description, Business Overview
4.7.3 Dong-A ST Erectile Dysfunction Drugs Products Offered
4.7.4 Dong-A ST Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2017-2022)
4.7.5 Dong-A ST Erectile Dysfunction Drugs Sales by Product in 2021
4.7.6 Dong-A ST Erectile Dysfunction Drugs Sales by Application in 2021
4.7.7 Dong-A ST Erectile Dysfunction Drugs Sales by Geographic Area in 2021
4.7.8 Dong-A ST Recent Development
4.8 Metuchen Pharma
4.8.1 Metuchen Pharma Corporation Information
4.8.2 Metuchen Pharma Description, Business Overview
4.8.3 Metuchen Pharma Erectile Dysfunction Drugs Products Offered
4.8.4 Metuchen Pharma Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2017-2022)
4.8.5 Metuchen Pharma Erectile Dysfunction Drugs Sales by Product in 2021
4.8.6 Metuchen Pharma Erectile Dysfunction Drugs Sales by Application in 2021
4.8.7 Metuchen Pharma Erectile Dysfunction Drugs Sales by Geographic Area in 2021
4.8.8 Metuchen Pharma Recent Development
4.9 Seoul Pharma
4.9.1 Seoul Pharma Corporation Information
4.9.2 Seoul Pharma Description, Business Overview
4.9.3 Seoul Pharma Erectile Dysfunction Drugs Products Offered
4.9.4 Seoul Pharma Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2017-2022)
4.9.5 Seoul Pharma Erectile Dysfunction Drugs Sales by Product in 2021
4.9.6 Seoul Pharma Erectile Dysfunction Drugs Sales by Application in 2021
4.9.7 Seoul Pharma Erectile Dysfunction Drugs Sales by Geographic Area in 2021
4.9.8 Seoul Pharma Recent Development
4.10 CSBIO.
4.10.1 CSBIO. Corporation Information
4.10.2 CSBIO. Description, Business Overview
4.10.3 CSBIO. Erectile Dysfunction Drugs Products Offered
4.10.4 CSBIO. Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2017-2022)
4.10.5 CSBIO. Erectile Dysfunction Drugs Sales by Product in 2021
4.10.6 CSBIO. Erectile Dysfunction Drugs Sales by Application in 2021
4.10.7 CSBIO. Erectile Dysfunction Drugs Sales by Geographic Area in 2021
4.10.8 CSBIO. Recent Development
5 Breakdown Data by Type
5.1 Global Erectile Dysfunction Drugs Sales by Type (2017-2028)
5.1.1 Global Erectile Dysfunction Drugs Sales by Type (2017-2022)
5.1.2 Global Erectile Dysfunction Drugs Sales Forecast by Type (2023-2028)
5.1.3 Global Erectile Dysfunction Drugs Sales Market Share by Type (2017-2028)
5.2 Global Erectile Dysfunction Drugs Revenue Forecast by Type (2017-2028)
5.2.1 Global Erectile Dysfunction Drugs Revenue by Type (2017-2022)
5.2.2 Global Erectile Dysfunction Drugs Revenue Forecast by Type (2023-2028)
5.2.3 Global Erectile Dysfunction Drugs Revenue Market Share by Type (2017-2028)
5.3 Erectile Dysfunction Drugs Average Selling Price (ASP) by Type (2017-2028)
6 Breakdown Data by Application
6.1 Global Erectile Dysfunction Drugs Sales by Application (2017-2028)
6.1.1 Global Erectile Dysfunction Drugs Sales by Application (2017-2022)
6.1.2 Global Erectile Dysfunction Drugs Sales Forecast by Application (2023-2028)
6.1.3 Global Erectile Dysfunction Drugs Sales Market Share by Application (2017-2028)
6.2 Global Erectile Dysfunction Drugs Revenue Forecast by Application (2017-2028)
6.2.1 Global Erectile Dysfunction Drugs Revenue by Application (2017-2022)
6.2.2 Global Erectile Dysfunction Drugs Revenue Forecast by Application (2023-2028)
6.2.3 Global Erectile Dysfunction Drugs Revenue Market Share by Application (2017-2028)
6.3 Erectile Dysfunction Drugs Average Selling Price (ASP) by Application (2017-2028)
7 North America
7.1 North America Erectile Dysfunction Drugs Market Size YoY Growth 2017-2028
7.2 North America Erectile Dysfunction Drugs Market Facts & Figures by Country
7.2.1 North America Erectile Dysfunction Drugs Sales by Country (2017-2028)
7.2.2 North America Erectile Dysfunction Drugs Revenue by Country (2017-2028)
7.3 North America Erectile Dysfunction Drugs Sales by Type
7.4 North America Erectile Dysfunction Drugs Sales by Application
8 Asia-Pacific
8.1 Asia-Pacific Erectile Dysfunction Drugs Market Size YoY Growth 2017-2028
8.2 Asia-Pacific Erectile Dysfunction Drugs Market Facts & Figures by Region
8.2.1 Asia-Pacific Erectile Dysfunction Drugs Sales by Region (2017-2028)
8.2.2 Asia-Pacific Erectile Dysfunction Drugs Revenue by Region (2017-2028)
8.3 Asia-Pacific Erectile Dysfunction Drugs Sales by Type
8.4 Asia-Pacific Erectile Dysfunction Drugs Sales by Application
9 Europe
9.1 Europe Erectile Dysfunction Drugs Market Size YoY Growth 2017-2028
9.2 Europe Erectile Dysfunction Drugs Market Facts & Figures by Country
9.2.1 Europe Erectile Dysfunction Drugs Sales by Country (2017-2028)
9.2.2 Europe Erectile Dysfunction Drugs Revenue by Country (2017-2028)
9.3 Europe Erectile Dysfunction Drugs Sales by Type
9.4 Europe Erectile Dysfunction Drugs Sales by Application
10 Latin America
10.1 Latin America Erectile Dysfunction Drugs Market Size YoY Growth 2017-2028
10.2 Latin America Erectile Dysfunction Drugs Market Facts & Figures by Country
10.2.1 Latin America Erectile Dysfunction Drugs Sales by Country (2017-2028)
10.2.2 Latin America Erectile Dysfunction Drugs Revenue by Country (2017-2028)
10.3 Latin America Erectile Dysfunction Drugs Sales by Type
10.4 Latin America Erectile Dysfunction Drugs Sales by Application
11 Middle East and Africa
11.1 Middle East and Africa Erectile Dysfunction Drugs Market Size YoY Growth 2017-2028
11.2 Middle East and Africa Erectile Dysfunction Drugs Market Facts & Figures by Country
11.2.1 Middle East and Africa Erectile Dysfunction Drugs Sales by Country (2017-2028)
11.2.2 Middle East and Africa Erectile Dysfunction Drugs Revenue by Country (2017-2028)
11.3 Middle East and Africa Erectile Dysfunction Drugs Sales by Type
11.4 Middle East and Africa Erectile Dysfunction Drugs Sales by Application
12 Supply Chain and Sales Channel Analysis
12.1 Erectile Dysfunction Drugs Supply Chain Analysis
12.2 Erectile Dysfunction Drugs Key Raw Materials and Upstream Suppliers
12.3 Erectile Dysfunction Drugs Clients Analysis
12.4 Erectile Dysfunction Drugs Sales Channel and Sales Model Analysis
12.4.1 Erectile Dysfunction Drugs Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Erectile Dysfunction Drugs Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Erectile Dysfunction Drugs Distributors
13 Market Dynamics
13.1 Erectile Dysfunction Drugs Industry Trends
13.2 Erectile Dysfunction Drugs Market Drivers
13.3 Erectile Dysfunction Drugs Market Challenges
13.4 Erectile Dysfunction Drugs Market Restraints
13.5 Porter’s Five Forces Analysis
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
    Table 1. Global Erectile Dysfunction Drugs Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Major Manufacturers of Sildenafil
    Table 3. Major Manufacturers of Tadalafil
    Table 4. Major Manufacturers of Others
    Table 5. Global Erectile Dysfunction Drugs Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Erectile Dysfunction Drugs Market Size by Region (US$ Million): 2021 VS 2022 VS 2028
    Table 7. Global Erectile Dysfunction Drugs Sales by Region (2017-2022) & (M Pill)
    Table 8. Global Erectile Dysfunction Drugs Sales Forecast by Region (2023-2028) & (M Pill)
    Table 9. Global Erectile Dysfunction Drugs Revenue by Region (2017-2022) & (US$ Million)
    Table 10. Global Erectile Dysfunction Drugs Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 11. Global Erectile Dysfunction Drugs Sales by Manufacturer (2017-2022) & (M Pill)
    Table 12. Global Erectile Dysfunction Drugs Sales Share by Manufacturer (2017-2022)
    Table 13. Erectile Dysfunction Drugs Revenue by Manufacturer (2017-2022) & (US$ Million)
    Table 14. Erectile Dysfunction Drugs Revenue Share by Manufacturer (2017-2022)
    Table 15. Key Manufacturers Erectile Dysfunction Drugs Price (2017-2022) & (USD/Pill)
    Table 16. Ranking of Global Top Erectile Dysfunction Drugs Manufacturers by Revenue (US$ Million) in 2021
    Table 17. Global Erectile Dysfunction Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) & (2017-2022)
    Table 18. Global Erectile Dysfunction Drugs by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Erectile Dysfunction Drugs as of 2021)
    Table 19. Erectile Dysfunction Drugs Manufacturers Manufacturing Base Distribution and Headquarters
    Table 20. Manufacturers Erectile Dysfunction Drugs Product Type
    Table 21. Date of International Manufacturers Enter into Erectile Dysfunction Drugs Market
    Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 23. Eli Lilly Corporation Information
    Table 24. Eli Lilly Description and Business Overview
    Table 25. Eli Lilly Erectile Dysfunction Drugs Sales (M Pill), Revenue (US$ Million), Price (USD/Pill) and Gross Margin (2017-2022)
    Table 26. Eli Lilly Erectile Dysfunction Drugs Product
    Table 27. Eli Lilly Erectile Dysfunction Drugs Sales Proportion of Erectile Dysfunction Drugs by Product in 2021
    Table 28. Eli Lilly Erectile Dysfunction Drugs Sales Proportion of Erectile Dysfunction Drugs by Application in 2021
    Table 29. Eli Lilly Erectile Dysfunction Drugs Sales Proportion of Erectile Dysfunction Drugs by Geographic Area in 2021
    Table 30. Eli Lilly Recent Development
    Table 31. Pfizer Corporation Information
    Table 32. Pfizer Description and Business Overview
    Table 33. Pfizer Erectile Dysfunction Drugs Sales (M Pill), Revenue (US$ Million), Price (USD/Pill) and Gross Margin (2017-2022)
    Table 34. Pfizer Erectile Dysfunction Drugs Product
    Table 35. Pfizer Erectile Dysfunction Drugs Sales Proportion of Erectile Dysfunction Drugs by Product in 2021
    Table 36. Pfizer Erectile Dysfunction Drugs Sales Proportion of Erectile Dysfunction Drugs by Application in 2021
    Table 37. Pfizer Erectile Dysfunction Drugs Sales Proportion of Erectile Dysfunction Drugs by Geographic Area in 2021
    Table 38. Pfizer Recent Development
    Table 39. Bayer Corporation Information
    Table 40. Bayer Description and Business Overview
    Table 41. Bayer Erectile Dysfunction Drugs Sales (M Pill), Revenue (US$ Million), Price (USD/Pill) and Gross Margin (2017-2022)
    Table 42. Bayer Erectile Dysfunction Drugs Product
    Table 43. Bayer Erectile Dysfunction Drugs Sales Proportion of Erectile Dysfunction Drugs by Product in 2021
    Table 44. Bayer Erectile Dysfunction Drugs Sales Proportion of Erectile Dysfunction Drugs by Application in 2021
    Table 45. Bayer Erectile Dysfunction Drugs Sales Proportion of Erectile Dysfunction Drugs by Geographic Area in 2021
    Table 46. Bayer Recent Development
    Table 47. BaiYunShan General Factory Corporation Information
    Table 48. BaiYunShan General Factory Description and Business Overview
    Table 49. BaiYunShan General Factory Erectile Dysfunction Drugs Sales (M Pill), Revenue (US$ Million), Price (USD/Pill) and Gross Margin (2017-2022)
    Table 50. BaiYunShan General Factory Erectile Dysfunction Drugs Product
    Table 51. BaiYunShan General Factory Erectile Dysfunction Drugs Sales Proportion of Erectile Dysfunction Drugs by Product in 2021
    Table 52. BaiYunShan General Factory Erectile Dysfunction Drugs Sales Proportion of Erectile Dysfunction Drugs by Application in 2021
    Table 53. BaiYunShan General Factory Erectile Dysfunction Drugs Sales Proportion of Erectile Dysfunction Drugs by Geographic Area in 2021
    Table 54. BaiYunShan General Factory Recent Development
    Table 55. S.K. Chemicals Corporation Information
    Table 56. S.K. Chemicals Description and Business Overview
    Table 57. S.K. Chemicals Erectile Dysfunction Drugs Sales (M Pill), Revenue (US$ Million), Price (USD/Pill) and Gross Margin (2017-2022)
    Table 58. S.K. Chemicals Erectile Dysfunction Drugs Product
    Table 59. S.K. Chemicals Erectile Dysfunction Drugs Sales Proportion of Erectile Dysfunction Drugs by Product in 2021
    Table 60. S.K. Chemicals Erectile Dysfunction Drugs Sales Proportion of Erectile Dysfunction Drugs by Application in 2021
    Table 61. S.K. Chemicals Erectile Dysfunction Drugs Sales Proportion of Erectile Dysfunction Drugs by Geographic Area in 2021
    Table 62. S.K. Chemicals Recent Development
    Table 63. Teva Pharma Corporation Information
    Table 64. Teva Pharma Description and Business Overview
    Table 65. Teva Pharma Erectile Dysfunction Drugs Sales (M Pill), Revenue (US$ Million), Price (USD/Pill) and Gross Margin (2017-2022)
    Table 66. Teva Pharma Erectile Dysfunction Drugs Product
    Table 67. Teva Pharma Erectile Dysfunction Drugs Sales Proportion of Erectile Dysfunction Drugs by Product in 2021
    Table 68. Teva Pharma Erectile Dysfunction Drugs Sales Proportion of Erectile Dysfunction Drugs by Application in 2021
    Table 69. Teva Pharma Erectile Dysfunction Drugs Sales Proportion of Erectile Dysfunction Drugs by Geographic Area in 2021
    Table 70. Dong-A ST Corporation Information
    Table 71. Dong-A ST Description and Business Overview
    Table 72. Dong-A ST Erectile Dysfunction Drugs Sales (M Pill), Revenue (US$ Million), Price (USD/Pill) and Gross Margin (2017-2022)
    Table 73. Dong-A ST Erectile Dysfunction Drugs Product
    Table 74. Dong-A ST Erectile Dysfunction Drugs Sales Proportion of Erectile Dysfunction Drugs by Product in 2021
    Table 75. Dong-A ST Erectile Dysfunction Drugs Sales Proportion of Erectile Dysfunction Drugs by Application in 2021
    Table 76. Dong-A ST Erectile Dysfunction Drugs Sales Proportion of Erectile Dysfunction Drugs by Geographic Area in 2021
    Table 77. Metuchen Pharma Corporation Information
    Table 78. Metuchen Pharma Description and Business Overview
    Table 79. Metuchen Pharma Erectile Dysfunction Drugs Sales (M Pill), Revenue (US$ Million), Price (USD/Pill) and Gross Margin (2017-2022)
    Table 80. Metuchen Pharma Erectile Dysfunction Drugs Product
    Table 81. Metuchen Pharma Erectile Dysfunction Drugs Sales Proportion of Erectile Dysfunction Drugs by Product in 2021
    Table 82. Metuchen Pharma Erectile Dysfunction Drugs Sales Proportion of Erectile Dysfunction Drugs by Application in 2021
    Table 83. Metuchen Pharma Erectile Dysfunction Drugs Sales Proportion of Erectile Dysfunction Drugs by Geographic Area in 2021
    Table 84. Seoul Pharma Corporation Information
    Table 85. Seoul Pharma Description and Business Overview
    Table 86. Seoul Pharma Erectile Dysfunction Drugs Sales (M Pill), Revenue (US$ Million), Price (USD/Pill) and Gross Margin (2017-2022)
    Table 87. Seoul Pharma Erectile Dysfunction Drugs Product
    Table 88. Seoul Pharma Erectile Dysfunction Drugs Sales Proportion of Erectile Dysfunction Drugs by Product in 2021
    Table 89. Seoul Pharma Erectile Dysfunction Drugs Sales Proportion of Erectile Dysfunction Drugs by Application in 2021
    Table 90. Seoul Pharma Erectile Dysfunction Drugs Sales Proportion of Erectile Dysfunction Drugs by Geographic Area in 2021
    Table 91. CSBIO. Corporation Information
    Table 92. CSBIO. Description and Business Overview
    Table 93. CSBIO. Erectile Dysfunction Drugs Sales (M Pill), Revenue (US$ Million), Price (USD/Pill) and Gross Margin (2017-2022)
    Table 94. CSBIO. Erectile Dysfunction Drugs Product
    Table 95. CSBIO. Erectile Dysfunction Drugs Sales Proportion of Erectile Dysfunction Drugs by Product in 2021
    Table 96. CSBIO. Erectile Dysfunction Drugs Sales Proportion of Erectile Dysfunction Drugs by Application in 2021
    Table 97. CSBIO. Erectile Dysfunction Drugs Sales Proportion of Erectile Dysfunction Drugs by Geographic Area in 2021
    Table 98. Global Erectile Dysfunction Drugs Sales by Type (2017-2022) & (M Pill)
    Table 99. Global Erectile Dysfunction Drugs Sales Forecast by Type (2023-2028) & (M Pill)
    Table 100. Global Erectile Dysfunction Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 101. Global Erectile Dysfunction Drugs Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 102. Global Erectile Dysfunction Drugs Sales by Application (2017-2022) & (M Pill)
    Table 103. Global Erectile Dysfunction Drugs Sales Forecast by Application (2023-2028) & (M Pill)
    Table 104. Global Erectile Dysfunction Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 105. Global Erectile Dysfunction Drugs Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 106. North America Erectile Dysfunction Drugs Sales by Country (2017-2022) & (M Pill)
    Table 107. North America Erectile Dysfunction Drugs Sales by Country (2023-2028) & (M Pill)
    Table 108. North America Erectile Dysfunction Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 109. North America Erectile Dysfunction Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 110. North America Erectile Dysfunction Drugs Sales by Type (2017-2022) & (M Pill)
    Table 111. North America Erectile Dysfunction Drugs Sales by Application (2017-2022) & (M Pill)
    Table 112. Asia-Pacific Erectile Dysfunction Drugs Sales by Region (2017-2022) & (M Pill)
    Table 113. Asia-Pacific Erectile Dysfunction Drugs Sales by Region (2023-2028) & (M Pill)
    Table 114. Asia-Pacific Erectile Dysfunction Drugs Revenue by Region (2017-2028) & (US$ Million)
    Table 115. Asia-Pacific Erectile Dysfunction Drugs Revenue by Region (2023-2028) & (US$ Million)
    Table 116. Asia-Pacific Erectile Dysfunction Drugs Sales by Type (2017-2022) & (M Pill)
    Table 117. Asia-Pacific Erectile Dysfunction Drugs Sales by Application (2017-2022) & (M Pill)
    Table 118. Europe Erectile Dysfunction Drugs Sales by Country (2017-2022) & (M Pill)
    Table 119. Europe Erectile Dysfunction Drugs Sales by Country (2023-2028) & (M Pill)
    Table 120. Europe Erectile Dysfunction Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 121. Europe Erectile Dysfunction Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 122. Europe Erectile Dysfunction Drugs Sales by Type (2017-2022) & (M Pill)
    Table 123. Europe Erectile Dysfunction Drugs Sales by Application (2017-2022) & (M Pill)
    Table 124. Latin America Erectile Dysfunction Drugs Sales by Country (2017-2022) & (M Pill)
    Table 125. Latin America Erectile Dysfunction Drugs Sales by Country (2023-2028) & (M Pill)
    Table 126. Latin America Erectile Dysfunction Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 127. Latin America Erectile Dysfunction Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 128. Latin America Erectile Dysfunction Drugs Sales by Type (2017-2022) & (M Pill)
    Table 129. Latin America Erectile Dysfunction Drugs Sales by Application (2017-2022) & (M Pill)
    Table 130. Middle East and Africa Erectile Dysfunction Drugs Sales by Country (2017-2022) & (M Pill)
    Table 131. Middle East and Africa Erectile Dysfunction Drugs Sales by Country (2023-2028) & (M Pill)
    Table 132. Middle East and Africa Erectile Dysfunction Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 133. Middle East and Africa Erectile Dysfunction Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 134. Middle East and Africa Erectile Dysfunction Drugs Sales by Type (2017-2022) & (M Pill)
    Table 135. Middle East and Africa Erectile Dysfunction Drugs Sales by Application (2017-2022) & (M Pill)
    Table 136. Erectile Dysfunction Drugs Key Raw Materials, Industry Status and Trend
    Table 137. Erectile Dysfunction Drugs Key Raw Materials and Upstream Suppliers
    Table 138. Erectile Dysfunction Drugs Clients Status and Trend
    Table 139. Erectile Dysfunction Drugs Typical Clients
    Table 140. Erectile Dysfunction Drugs Distributors
    Table 141. Erectile Dysfunction Drugs Market Trends
    Table 142. Erectile Dysfunction Drugs Market Drivers
    Table 143. Erectile Dysfunction Drugs Market Challenges
    Table 144. Erectile Dysfunction Drugs Market Restraints
    Table 145. Research Programs/Design for This Report
    Table 146. Key Data Information from Secondary Sources
    Table 147. Key Data Information from Primary Sources
List of Figures
    Figure 1. Erectile Dysfunction Drugs Product Picture
    Figure 2. Global Erectile Dysfunction Drugs Sales Market Share by Type in 2021 & 2028
    Figure 3. Sildenafil Product Picture
    Figure 4. Tadalafil Product Picture
    Figure 5. Others Product Picture
    Figure 6. Global Erectile Dysfunction Drugs Sales Market Share by Application in 2021 & 2028
    Figure 7. Hospital Pharmacies Examples
    Figure 8. Private Clinics Examples
    Figure 9. Retail Pharmacies Examples
    Figure 10. E-Commerce (B2B) Examples
    Figure 11. E-Commerce (B2C) Examples
    Figure 12. Erectile Dysfunction Drugs Report Years Considered
    Figure 13. Global Erectile Dysfunction Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Erectile Dysfunction Drugs Market Size 2017-2028 (US$ Million)
    Figure 15. Global Erectile Dysfunction Drugs Sales 2017-2028 (M Pill)
    Figure 16. Global Erectile Dysfunction Drugs Market Size Market Share by Region: 2022 Versus 2028
    Figure 17. Global Erectile Dysfunction Drugs Sales Market Share Forecast by Region (2017-2028)
    Figure 18. Global Erectile Dysfunction Drugs Revenue Market Share by Region (2017-2028)
    Figure 19. Global Erectile Dysfunction Drugs Sales Share by Manufacturer in 2021
    Figure 20. Erectile Dysfunction Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 21. Global Erectile Dysfunction Drugs Sales Market Share Forecast by Type (2017-2028)
    Figure 22. Global Erectile Dysfunction Drugs Revenue Market Share Forecast by Type (2017-2028)
    Figure 23. Erectile Dysfunction Drugs Average Selling Price (ASP) by Type (2017-2022) & (USD/Pill)
    Figure 24. Global Erectile Dysfunction Drugs Sales Market Share Forecast by Application (2017-2028)
    Figure 25. Global Erectile Dysfunction Drugs Revenue Market Share Forecast by Application (2017-2028)
    Figure 26. Erectile Dysfunction Drugs Average Selling Price (ASP) by Application (2017-2022) & (USD/Pill)
    Figure 27. North America Erectile Dysfunction Drugs Revenue 2017-2028 (US$ Million)
    Figure 28. North America Erectile Dysfunction Drugs Sales Market Share by Type (2017-2022)
    Figure 29. North America Erectile Dysfunction Drugs Sales Market Share by Application (2017-2022)
    Figure 30. Asia-Pacific Erectile Dysfunction Drugs Revenue 2017-2028 (US$ Million)
    Figure 31. Asia-Pacific Erectile Dysfunction Drugs Sales Market Share by Region (2017-2028)
    Figure 32. Asia-Pacific Erectile Dysfunction Drugs Revenue Market Share by Region (2017-2028)
    Figure 33. Asia-Pacific Erectile Dysfunction Drugs Sales Market Share by Type (2017-2022)
    Figure 34. Asia-Pacific Erectile Dysfunction Drugs Sales Market Share by Application (2017-2022)
    Figure 35. Europe Erectile Dysfunction Drugs Revenue Growth Rate 2017-2028 (US$ Million)
    Figure 36. Europe Erectile Dysfunction Drugs Sales Market Share by Country (2017-2028)
    Figure 37. Europe Erectile Dysfunction Drugs Revenue Market Share by Country (2017-2028)
    Figure 38. Europe Erectile Dysfunction Drugs Sales Market Share by Type (2017-2022)
    Figure 39. Europe Erectile Dysfunction Drugs Sales Market Share by Application (2017-2022)
    Figure 40. Latin America Erectile Dysfunction Drugs Revenue Growth Rate 2017-2028 (US$ Million)
    Figure 41. Latin America Erectile Dysfunction Drugs Sales Market Share by Country (2017-2028)
    Figure 42. Latin America Erectile Dysfunction Drugs Revenue Market Share by Country (2017-2022)
    Figure 43. Latin America Erectile Dysfunction Drugs Sales Market Share by Type (2017-2022)
    Figure 44. Latin America Erectile Dysfunction Drugs Sales Market Share by Application (2017-2022)
    Figure 45. Middle East and Africa Erectile Dysfunction Drugs Revenue Growth Rate 2017-2028 (US$ Million)
    Figure 46. Middle East and Africa Erectile Dysfunction Drugs Sales Market Share by Country (2017-2028)
    Figure 47. Middle East and Africa Erectile Dysfunction Drugs Revenue Market Share by Country (2017-2028)
    Figure 48. Middle East and Africa Erectile Dysfunction Drugs Sales Market Share by Type (2017-2022)
    Figure 49. Middle East and Africa Erectile Dysfunction Drugs Sales Market Share by Application (2017-2022)
    Figure 50. Erectile Dysfunction Drugs Supply Chain (Upstream and Downstream Market)
    Figure 51. Global Production Market Share of Erectile Dysfunction Drugs Raw Materials by Region in 2021
    Figure 52. Erectile Dysfunction Drugs Distribution Channels
    Figure 53. Global Erectile Dysfunction Drugs Percentage 2017-2028: Indirect Sales VS Direct Sales
    Figure 54. Global Erectile Dysfunction Drugs Percentage 2017-2028: Online Sales VS Offline Sales
    Figure 55. Bottom-up and Top-down Approaches for This Report
    Figure 56. Data Triangulation
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$5900
This license allows only one user to access the PDF.

Electronic (PDF)
$8850
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$11800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
SecuX Technology Inc
SIMILAR REPORTS